Condition: Leukemia, Acute Lymphoblastic · Sponsor: Mats Heyman
ALLTogether collects the experience of previously successful treatment of infants, children and young adults, with ALL from a number of well-renowned study groups into a new master protocol, which is both a comprehensive system for stratification and treatment of ALL in this age-group as well as the basis for several randomised and interventional trials included in the study-design.
This description comes directly from the study's public registry record.
Global Clinical Trial Manager ALLTogether1 · +46 8 123 700 00 · alltogether.karolinska@regionstockholm.se
Always discuss trial participation with your own doctor first.
| L'hôpital Universitaire des enfants Reine Fabiola (Huderf) | Brussels, Belgium | Recruiting |
| Cliniques Universitaires Saint-Luc (UCL) | Brussels, Belgium | Recruiting |
| University Hospital Antwerp | Edegem, Belgium | Recruiting |
| University Hospital Ghent | Ghent, Belgium | Recruiting |
| University Hospital Leuven, Dept of Paediatrics | Leuven, Belgium | Recruiting |
| CHC MontLégia, Boulevard Patience et Beaujonc 2 | Liège, Belgium | Recruiting |
| CHR de la Citadelle | Liège, Belgium | Recruiting |
| Aalborg University Hospital, Dept of Paediatrics | Aalborg, Denmark | Recruiting |
| Aarhus University Hospital | Aarhus, Denmark | Recruiting |
| Aarhus University Hospital, Child and Adolescent Health | Aarhus, Denmark | Recruiting |
| Rigshospitalet, Dept of Haematology | Copenhagen, Denmark | Recruiting |
| Rigshospitalet, Dept of Paediatrics | Copenhagen, Denmark | Recruiting |
+ 126 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04307576